144 related articles for article (PubMed ID: 17186137)
1. The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis.
Eryol NK; Dogan A; Ozdogru I; Inanc MT; Kaya MG; Kalay N
Int J Cardiovasc Imaging; 2007 Oct; 23(5):569-74. PubMed ID: 17186137
[TBL] [Abstract][Full Text] [Related]
2. N-terminal proBNP plasma levels correlate with severity of mitral stenosis.
Iltumur K; Karabulut A; Yokus B; Yavuzkir M; Taskesen T; Toprak N
J Heart Valve Dis; 2005 Nov; 14(6):735-41. PubMed ID: 16359052
[TBL] [Abstract][Full Text] [Related]
3. Plasma brain natriuretic peptide levels in patients with rheumatic heart disease.
Gölbaşý Z; Uçar O; Yüksel AG; Gülel O; Aydoğdu S; Ulusoy V
Eur J Heart Fail; 2004 Oct; 6(6):757-60. PubMed ID: 15542413
[TBL] [Abstract][Full Text] [Related]
4. Serum N-terminal brain natriuretic peptide indicates exercise induced augmentation of pulmonary artery pressure in patients with mitral stenosis.
Kilickesmez KO; Ozkan AA; Abaci O; Camlıca H; Kocas C; Kaya A; Baskurt M; Yiğit Z; Kucukoğlu S
Echocardiography; 2011 Jan; 28(1):8-14. PubMed ID: 20738368
[TBL] [Abstract][Full Text] [Related]
5. QT dispersion in patients with rheumatic mitral stenosis and its relation with echocardiographic findings and serum NT-proBNP levels.
Kılıçkesmez KO; Bulut G; Başkurt M; Coşkun U; Yıldız A; Küçükoğlu S
Turk Kardiyol Dern Ars; 2011 Apr; 39(3):183-90. PubMed ID: 21532293
[TBL] [Abstract][Full Text] [Related]
6. Comparison of atrial and brain natriuretic peptide for the assessment of mitral stenosis.
Sharma V; Stewart RA; Zeng I; Raffel C; Kerr AJ
Heart Lung Circ; 2011 Aug; 20(8):517-24. PubMed ID: 21600847
[TBL] [Abstract][Full Text] [Related]
7. Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis.
Cemri M; Arslan U; Kocaman SA; Cengel A
J Postgrad Med; 2008; 54(1):12-6. PubMed ID: 18296798
[TBL] [Abstract][Full Text] [Related]
8. Determinants of the reduction in B-type natriuretic peptide after mitral valve replacement in patients with rheumatic mitral stenosis.
Leszek P; Klisiewicz A; Janas J; Różański J; Rywik T; Piotrowski W; Korewicki J
Clin Physiol Funct Imaging; 2010 Nov; 30(6):473-9. PubMed ID: 20807228
[TBL] [Abstract][Full Text] [Related]
9. Serum N-terminal pro-BNP levels correlate with symptoms and echocardiographic findings in patients with mitral stenosis.
Arat-Ozkan A; Kaya A; Yigit Z; Balci H; Okçün B; Yazicioglu N; Küçükoglu S
Echocardiography; 2005 Jul; 22(6):473-8. PubMed ID: 15966931
[TBL] [Abstract][Full Text] [Related]
10. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation.
Shang YP; Lai L; Chen J; Zhang F; Wang X
J Heart Valve Dis; 2005 Jul; 14(4):453-9. PubMed ID: 16116870
[TBL] [Abstract][Full Text] [Related]
11. The change in NT-pro-BNP and post-PTMC echocardiography parameters in patients with mitral stenosis. A pilot study.
Safi M; Bayat F; Ahmadi Z; Shekarchizadeh M; Khaheshi I; Naderian M
Rom J Intern Med; 2017 Jun; 55(2):75-81. PubMed ID: 28103203
[TBL] [Abstract][Full Text] [Related]
12. Valvular heart disease: plasma B-type natriuretic peptide levels in patients with pure rheumatic mitral stenosis.
Uçar O; Bayar N; Karagöz A; Aydoğdu S
Acta Cardiol; 2012 Feb; 67(1):59-64. PubMed ID: 22455090
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic assessment of mitral stenosis: mitral valve resistance as an echocardiographic index.
Tanboga IH; Kurt M; Ekinci M; Isik T; Kaya A; Bilen E; Aksakal E
J Heart Valve Dis; 2012 Mar; 21(2):203-7. PubMed ID: 22645856
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
[TBL] [Abstract][Full Text] [Related]
15. The impact of right ventricular stroke work on B-type natriuretic peptide levels in patients with mitral stenosis undergoing percutaneous mitral valvuloplasty.
Esteves WA; Lodi-Junqueira L; Neto CP; Tan TC; Nascimento BR; Mehrotra P; Barbosa MM; Ribeiro AL; Nunes MC
J Interv Cardiol; 2013 Oct; 26(5):501-8. PubMed ID: 23879382
[TBL] [Abstract][Full Text] [Related]
16. The effect of percutaneous balloon mitral valvuloplasty on N-terminal- pro B- type natriuretic peptide plasma levels in mitral stenosis.
Selcuk MT; Selcuk H; Maden O; Erbay AR; Temizhan A; Aksu T; Saydam GS; Korkmaz S
Int Heart J; 2007 Sep; 48(5):579-90. PubMed ID: 17998767
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of B-type natriuretic peptide (NT-proBNP) levels and conventional and tissue Doppler echocardiographic parameters of left ventricular diastolic function in patients with hypertrophic cardiomyopathy].
Faludi R; Tóth L; Pótó L; Cziráki A; Simor T; Papp L
Orv Hetil; 2005 Jan; 146(1):23-6. PubMed ID: 15715369
[TBL] [Abstract][Full Text] [Related]
18. The relationship between plasma proadrenomedullin level and severity of the disease in patients with isolated rheumatic mitral stenosis.
Demir AR; Çetin İ; Kalkan AK; Avcı Y; Altunova M; Uygur B; Yılmaz E; Ertürk M
Turk Kardiyol Dern Ars; 2021 Oct; 49(7):522-532. PubMed ID: 34623294
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
[TBL] [Abstract][Full Text] [Related]
20. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation.
Yusoff R; Clayton N; Keevil B; Morris J; Ray S
Am J Cardiol; 2006 May; 97(10):1498-501. PubMed ID: 16679092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
